We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,516

Illinois Health Facilities and Services Review Board publishes guidelines for public participation
  • McDermott Will & Emery
  • USA
  • January 3 2013

The Illinois Health Facilities and Services Review Board (the Board) recently released new Guidelines for Public Participation at its meetings


Thinking outside the HIPAA box
  • McDermott Will & Emery
  • USA
  • May 9 2014

On Wednesday, May 7, the Federal Trade Commission (FTC) held the third of its Spring Seminars on emerging consumer privacy issues. This session


What is “a patient?”
  • McDermott Will & Emery
  • USA
  • May 29 2014

On appeal from summary judgment, the U.S. Court of Appeals for the Federal Circuit construed “a patient” to mean “a population of patients,”


A combination of references need only provide a “reasonable expectation of success”
  • McDermott Will & Emery
  • USA
  • May 29 2014

Addressing the validity of a dosing regimen patent in Abbreviated New Drug Application (ANDA) litigation, the U.S. Court of Appeals for the Federal


IRS and DOL guidance clarifies employee benefits impact of Supreme Court’s DOMA ruling
  • McDermott Will & Emery
  • USA
  • September 30 2013

Recent guidance issued by the U.S. Department of the Treasury, the Internal Revenue Service (IRS) and the Employee Benefits Security Administration


U.S. Department of Labor Issues Proposed Regulations Amending the COBRA Notice Requirements
  • McDermott Will & Emery
  • USA
  • May 6 2014

On May 2, 2014, the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) issued proposed regulations which seek to amend


The case of ophthalmic drugs in Italy and France: a lesson to learn - parallel antitrust investigations and cooperation between national competition authorities
  • McDermott Will & Emery
  • European Union, France, Italy
  • May 7 2014

The recent investigations into two pharmaceutical companies active in the ophthalmic drugs market in Italy and France serve as a reminder of the


The new normal: big data comes of age
  • McDermott Will & Emery
  • USA
  • May 13 2014

On May 1, 2014, the White House released two reports addressing the public policy implications of the proliferation of big data. The first report is


CMS releases final rule establishing Medicare prospective payment system for FQHCs
  • McDermott Will & Emery
  • USA
  • May 7 2014

On April 29, 2014, the Centers for Medicare & Medicaid Services (CMS) released a final rule establishing a Medicare prospective payment system for


CMS proposal to implement new metropolitan areas would affect Medicare payments for most hospitals
  • McDermott Will & Emery
  • USA
  • May 6 2014

The Centers for Medicare & Medicaid Services (CMS) recently issued the federal Fiscal Year 2015 Medicare Inpatient Prospective Payment System